600222 logo

Henan Taloph Pharmaceutical Stock Co.,Ltd Stock Price

SHSE:600222 Community·CN¥3.9b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

600222 Share Price Performance

CN¥0
-5.12 (-100.00%)
CN¥0
-5.12 (-100.00%)
Price CN¥0

600222 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Proven track record with adequate balance sheet.

0 Risks
1 Reward

Henan Taloph Pharmaceutical Stock Co.,Ltd Key Details

CN¥1.8b

Revenue

CN¥1.3b

Cost of Revenue

CN¥492.2m

Gross Profit

CN¥432.2m

Other Expenses

CN¥60.0m

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
Apr 24, 2026
0.11
28.00%
3.41%
44.9%
View Full Analysis

About 600222

Founded
1993
Employees
2214
CEO
Jingliang Li
WebsiteView website
www.taloph.com

Henan Taloph Pharmaceutical Stock Co.,Ltd engages in the research, development, and sale of pharmaceutical preparations and Chinese herbal medicines in China. Its principal products include Shuanghuanglian oral liquid series, Shuangjinlian mixture, pediatric Qingrezhike oral liquid, Huoxiangzhengqi mixture, Danshen and Wuzi Yanzong oral liquid, Shengmaiyin, pediatric compound chicken gizzard chewable tablets, Huperzine A tablets, compound Yimu oral liquid. The company serves hospitals, primary medical institutions, and retail terminals. Henan Taloph Pharmaceutical Stock Co.,Ltd was formerly known as Henan Joyline & Joysun Pharmaceutical Stock Co., Ltd. The company was founded in 1993 and is based in Zhengzhou, China.

Recent 600222 News & Updates

Recent updates

No updates